Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data. | Bioengineered | 2022 | 35521691 | PubTator, text mining | PubMed |
| Signature of Alzheimer's Disease in Intestinal Microbiome: Results From the AlzBiom Study. | Front Neurosci | 2022 | 35516807 | PubTator, text mining | PubMed |
| Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles. | ACS Nano | 2022 | 35507641 | PubTator, text mining | PubMed |
| COVID-19 Coagulopathy: From Pathogenesis to Treatment. | Acta Haematol | 2022 | 35499460 | PubTator, text mining | PubMed |
| The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. | World Allergy Organ J | 2022 | 35497649 | PubTator, text mining | PubMed |
| Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside. | Front Immunol | 2022 | 35493497 | PubTator, text mining | PubMed |
| A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients. | Front Cell Dev Biol | 2022 | 35493104 | PubTator, text mining | PubMed |
| Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials. | Int Immunopharmacol | 2022 | 35483235 | PubTator, text mining | PubMed |
| Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome. | Cureus | 2022 | 35481304 | PubTator, text mining | PubMed |
| A case of acquired angioedema. | JAAPA | 2022 | 35472033 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators. | J Clin Med | 2022 | 35456324 | PubTator, text mining | PubMed |
| Non-Coding RNAs Are Brokers in Breast Cancer Interactome Networks and Add Discrimination Power between Subtypes. | J Clin Med | 2022 | 35456196 | PubTator, text mining | PubMed |
| Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. | Cancers (Basel) | 2022 | 35454765 | PubTator, text mining | PubMed |
| First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation. | Biomedicines | 2022 | 35453504 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| patcHwork: a user-friendly pH sensitivity analysis web server for protein sequences and structures. | Nucleic Acids Res | 2022 | 35438792 | PubTator, text mining | PubMed |
| Proteomic Analysis of Serum Lysine Acetylation in Uyghur Patients With T2DM. | Front Mol Biosci | 2022 | 35433838 | PubTator, text mining | PubMed |
| Innovative immunosuppression in kidney transplantation: A challenge for unmet needs. | World J Transplant | 2022 | 35433332 | PubTator, text mining | PubMed |
| Identification of Potential Core Genes for the Rupture of Intracranial Aneurysms by a Bioinformatics Analysis. | Front Genet | 2022 | 35432454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=52